Back to top
more

Nu Skin Enterprises (NUS)

(Real Time Quote from BATS)

$7.09 USD

7.09
492,662

+0.54 (8.24%)

Updated Nov 11, 2024 12:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 250)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Factors to Decide the Fate of Coca-Cola (KO) in Q2 Earnings

by Zacks Equity Research

Coca-Cola's (KO) Q2 results are likely to reflect the impacts of declines in away-from-home channels and adverse currency. Growth in e-commerce is likely to have party cushioned its performance.

The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Nu Skin Enterprises, Clorox, B&G Foods, Nomad Foods and Kellogg

Boston Beer (SAM) to Report Q2 Earnings: What to Expect?

by Zacks Equity Research

Boston Beer's (SAM) Q2 results are likely to reflect continued gains from strength in depletions and shipments. Soft on-premise demand and higher costs are expected to have marred its performance.

Vrishali Bagree headshot

5 Consumer Staple Stocks to Buy With Earnings Beat Potential

by Vrishali Bagree

We have picked five consumer staple stocks, which are likely to report earnings beat this season owing to the burgeoning demand amid the pandemic-led increased at-home consumption.

Top Ranked Growth Stocks to Buy for July 15th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 15th.

Estee Lauder's (EL) Robust E-commerce Business Bodes Well

by Zacks Equity Research

Estee Lauder (EL) is benefiting from impressive cost-saving efforts amid the pandemic. The company's robust digital sales are cushioning from the coronavirus outbreak-led store closures.

Helen of Troy (HELE) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

Helen of Troy (HELE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Philip Morris' (PM) IQOS Gets FDA Nod to be Marketed as MRTP

by Zacks Equity Research

Philip Morris (PM) is likely to benefit from the FDA's latest move. Notably, the FDA authorizes IQOS's marketing as a modified risk tobacco product.

Moving Average Crossover Alert: Nu Skin Enterprises

by Zacks Equity Research

Nu Skin Enterprises, Inc. (NUS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Will Nu Skin Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor of Nu Skin Enterprises

Nu Skin (NUS) Revises Q2 Sales View Upward, Stock Rises

by Zacks Equity Research

Nu Skin (NUS) witnesses robust consumer growth during second-quarter 2020. The company raises sales guidance for the quarter.

Inter Parfums' IPSA Buys Stake in Owner of Origines-parfums

by Zacks Equity Research

Inter Parfums' (IPAR) majorly owned subsidiary ??? Interparfums SA or IPSA ??? pens a deal to buy 25% stake in Divabox. Divabox is the owner of Origines-parfums.

Coty (COTY) to Buy Stake in Kim Kardashian's Beauty Business

by Zacks Equity Research

Coty (COTY) announced its decision to buy 20% stake in Kim Kardashian's beauty business for $200 million.

3 Factors That Make Helen of Troy (HELE) an Attractive Pick

by Zacks Equity Research

Strength in Helen of Troy's (HELE) Leadership Brands is driving growth. Moreover, the company's focus on enhancing online business is yielding.

Rajani Lohia headshot

Tap Market Potential With These 4 Consumer Staples Stocks

by Rajani Lohia

Consumer staples sector shows resilience amid the pandemic due to strong demand for food and other essentials. Efforts to keep pace with consumer trends should bolster the sector's growth.

Kimberly-Clark (KMB) Looks Scrumptious on Cost-Saving Efforts

by Zacks Equity Research

Kimberly-Clark (KMB) is witnessing higher consumer demand owing to coronavirus induced stockpiling. Also, robust cost-saving efforts bode well.

Estee Lauder Benefits From Online Sales Amid Store Closures

by Zacks Equity Research

Estee Lauder (EL) is gaining from solid online sales amid coronavirus-led store closures. Also, the company's efficient cost-saving efforts are yielding.

The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises

by Zacks Equity Research

The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises

Why Nu Skin (NUS) Could Be a Top Value Stock Pick

by Zacks Equity Research

Nu Skin (NUS) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Vrishali Bagree headshot

5 Consumer Staple Dividend Stocks to Enrich Your Portfolio

by Vrishali Bagree

At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.

Kraft Heinz Pricing & Efficiency Building Efforts Bode Well

by Zacks Equity Research

Kraft Heinz (KHC) is benefitting from its robust pricing and product-development efforts. Also, the company's enterprise transformation strategies bode well.

Mondelez's Pricing Strategies Bodes Well, Input Costs a Woe

by Zacks Equity Research

Mondelez (MDLZ) is benefiting from efficient pricing and impressive savings plan. However, higher costs and unfavorable currency rates are troubling.

Here's Why Helen of Troy (HELE) is Up More Than 35% in a Year

by Zacks Equity Research

Helen of Troy's (HELE) focus on Leadership Brands, sturdy digital efforts and Transformation Plan bode well. It is seeing strong demand in the Health & Home unit thanks to the COVID-19 pandemic.

Nu Skin (NUS) Up 11.9% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why Nu Skin (NUS) Stock is Up More Than 40% in a Month

by Zacks Equity Research

Nu Skin (NUS) has been seeing improved trends in Mainland China as coronavirus-induced restrictions are being lifted in the region.